Company family
シオノケミカル: medicine shortages
As of 2 Nov 2026, 6 シオノケミカル products have a reported shortage across 1 countries, covering 6 medicines.
Products short6rank #290 of 464
Medicines6active ingredients
Countries1/16
New in 90 days00 vs market pace
Typical duration21 monthsmedian so far
Manufacturing17%demand-driven 50%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Cefaclor | 1 | 9 Jan 2025 | Manufacturing problem | 4/16 | |
| Clindamycin | 1 | 19 Dec 2024 | Increased demand | 4/16 | |
| Etoposide | 1 | 4 Mar 2025 | Increased demand | 7/16 | |
| Metformin | 1 | 28 Apr 2026 | Active ingredient shortage | 8/16 | |
| Montelukast | 1 | 21 Nov 2025 | Other | 13/16 | |
| Raloxifene | 1 | 22 Nov 2024 | Increased demand | 3/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.